Capital Impact Advisors LLC Has $188,000 Stock Position in Danaher Co. (NYSE:DHR)

Posted by Defense World Staff on Mar 16th, 2023

Capital Impact Advisors LLC lessened its stake in shares of Danaher Co. (NYSE:DHR – Get Rating) by 40.0% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 728 shares of the conglomerate’s stock after selling 485 shares during the quarter. Capital Impact Advisors LLC’s holdings in Danaher were worth $188,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of DHR. Vanguard Group Inc. raised its holdings in Danaher by 1.9% in the 3rd quarter. Vanguard Group Inc. now owns 53,690,131 shares of the conglomerate’s stock valued at $13,867,623,000 after buying an additional 995,501 shares during the last quarter. Northern Trust Corp lifted its stake in shares of Danaher by 0.8% in the second quarter. Northern Trust Corp now owns 8,061,833 shares of the conglomerate’s stock worth $2,043,836,000 after acquiring an additional 65,824 shares during the period. Legal & General Group Plc boosted its holdings in Danaher by 6.4% in the second quarter. Legal & General Group Plc now owns 4,656,373 shares of the conglomerate’s stock valued at $1,180,485,000 after acquiring an additional 279,432 shares during the last quarter. Amundi increased its position in Danaher by 10.2% during the 2nd quarter. Amundi now owns 4,649,220 shares of the conglomerate’s stock valued at $1,157,183,000 after purchasing an additional 431,694 shares during the period. Finally, Nuveen Asset Management LLC raised its holdings in Danaher by 8.5% during the 3rd quarter. Nuveen Asset Management LLC now owns 4,171,053 shares of the conglomerate’s stock worth $1,077,341,000 after purchasing an additional 328,151 shares during the last quarter. 77.26% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on DHR shares. Credit Suisse Group cut shares of Danaher from an “outperform” rating to a “neutral” rating and decreased their price objective for the stock from $315.00 to $300.00 in a research report on Thursday, January 5th. Barclays increased their target price on shares of Danaher from $277.00 to $290.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 24th. StockNews.com began coverage on shares of Danaher in a research note on Thursday. They issued a “buy” rating for the company. Cowen cut their price objective on shares of Danaher from $340.00 to $320.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 25th. Finally, Robert W. Baird reduced their price objective on Danaher from $321.00 to $309.00 in a research note on Wednesday, January 25th. Three equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $310.29.

Danaher Price Performance

Shares of NYSE DHR opened at $242.11 on Thursday. The company has a market capitalization of $176.40 billion, a PE ratio of 25.09, a PEG ratio of 1.97 and a beta of 0.80. The company has a quick ratio of 1.52, a current ratio of 1.89 and a debt-to-equity ratio of 0.39. The stock’s 50 day moving average price is $258.79 and its 200-day moving average price is $262.73. Danaher Co. has a twelve month low of $233.71 and a twelve month high of $303.82.

Danaher (NYSE:DHR – Get Rating) last announced its quarterly earnings data on Tuesday, January 24th. The conglomerate reported $2.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.46 by $0.41. Danaher had a return on equity of 17.97% and a net margin of 22.91%. The firm had revenue of $8.37 billion during the quarter, compared to the consensus estimate of $7.90 billion. During the same quarter in the prior year, the company earned $2.69 EPS. The business’s revenue for the quarter was up 2.7% on a year-over-year basis. On average, equities analysts anticipate that Danaher Co. will post 10.14 EPS for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 28th. Stockholders of record on Friday, March 31st will be issued a dividend of $0.27 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Thursday, March 30th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher’s payout ratio is presently 10.36%.

Insider Buying and Selling

In other Danaher news, Director Raymond C. Stevens sold 8,410 shares of Danaher stock in a transaction that occurred on Wednesday, January 25th. The shares were sold at an average price of $264.27, for a total transaction of $2,222,510.70. Following the completion of the sale, the director now directly owns 8,394 shares in the company, valued at $2,218,282.38. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 11.20% of the stock is owned by company insiders.

Danaher Profile

(Get Rating)

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services.